| Section | Status | HCD | Name |
| 05.03.01 | Formulary |  |
Abacavir |
| 05.03.01 | Formulary | |
Abacavir and Lamivudine |
| 06.06.01 | Formulary | |
Abaloparatide |
| 10.01.03 | Formulary | |
Abatacept Orencia® |
| 10.01.03 | Formulary | |
Adalimumab Biosimilars avaliable |
| 13.05.03 | Formulary | |
Adalimumab Biosimilars avaliable |
| 05.03.03 | Formulary | |
Adefovir Dipivoxil Hepsera® |
| 11.08.02 | Formulary | |
Aflibercept Eylea® |
| 13.05.01 | Formulary | |
Alitretinoin Toctino® |
| 05.02 | Formulary | |
Amphotericin B (liposomal) |
| 10.01.03 | Formulary | |
Anakinra Kineret® |
| 05.02.04 | Formulary | |
Anidulafungin |
| 13.05.03 | Formulary | |
Apremilast Otezla® |
| 05.03.01 | Formulary | |
Atazanavir |
| 05.03.01 | Formulary | |
Atazanavir sulfate and cobicistat Evotaz® |
| 10.01.03 | Formulary | |
Baricitinib Olumiant® |
| 10.01 | Formulary | |
Belimumab Benlysta® |
| 03.04.02 | Formulary | |
Benralizumab Fasenra® |
| 03.04.03 | Formulary | |
Berotralstat dihydrochloride Orladeyo® |
| 13.05.03 | Formulary | |
Brodalumab Kyntheum® |
| 05.02.04 | Formulary | |
Caspofungin |
| 10.01.03 | Formulary | |
Certolizumab Pegol Cimzia® |
| 05.03.01 | Formulary | |
Darunavir |
| 09.01.03 | Formulary | |
Deferasirox Exjade® |
| 09.01.03 | Formulary | |
Deferiprone Ferriprox® |
| 11.04.01 | Formulary | |
Dexamethasone intravitreal implant Ozurdex® |
| 08.02.04 | Formulary | |
Dimethyl fumarate Tecfidera® |
| 13.05.03 | Formulary | |
Dupilumab Dupixent® |
| 05.03.01 | Formulary | |
Efavirenz |
| 01.09.01 | Formulary | |
Elafibranor |
| 09.01.04 | Formulary | |
Eltrombopag Revolade® |
| 05.03.01 | Formulary | |
Emtricitabine Emtriva® |
| 05.03.03 | Formulary | |
Entecavir |
| 02.08.01 | Formulary | |
Epoprostenol |
| 10.01.03 | Formulary | |
Etanercept Biosimilars avaliable |
| 13.05.03 | Formulary | |
Etanercept Biosimilars avaliable |
| 05.03.01 | Formulary | |
Etravirine Intelence® |
| 08.02.04 | Formulary | |
Fingolimod |
| 11.04.01 | Formulary | |
Fluocinolone intravitreal implant Iluvien® |
| 05.03.01 | Formulary | |
Fostemsavir Rukobia® |
| 11.03.01 | Formulary | |
Fusidic Acid |
| 05.03.02.02 | Formulary | |
Ganciclovir |
| 10.01.03 | Formulary | |
Golimumab Simponi® |
| 02.12 | Formulary | |
Inclisiran Leqvio® |
| 10.01.03 | Formulary | |
Infliximab Biosimilars avaliable |
| 13.05.03 | Formulary | |
Infliximab Biosimilars avaliable |
| 13.05.02 | Formulary | |
Ixekizumab Taltz® |
| 08.03.04.03 | Formulary | |
Lanreotide |
| 09.05.02.02 | Formulary | |
Lanthanum Fosrenol ® |
| 13.05.03 | Formulary | |
Lebrikizumab |
| 08.03.04.03 | Formulary | |
Octreotide |
| 08.03.04.03 | Formulary | |
Octreotide |
| 13.05.03 | Formulary | |
Omalizumab |
| 11.08.02 | Formulary | |
Ranibizumab |
| 04.09.03 | Formulary | |
Riluzole Rilutek® |
| 01.05.03 | Formulary | |
Risankizumab Skyrizi® |
| 10.01.03 | Formulary | |
Risankizumab Skyrizi® |
| 13.05.03 | Formulary | |
Risankizumab Skyrizi® |
| 13.05.03 | Formulary | |
Ritlecitinib |
| 08.02.03 | Formulary | |
Rituximab |
| 09.01.03 | Formulary | |
Rituximab |
| 09.01.04 | Formulary | |
Rituximab idiopathic thrombocytopenia in adults |
| 10.01.03 | Formulary | |
Rituximab (rheumatology) Biosimilars avaliable |
| 09.01.04 | Formulary | |
Romiplostim Nplate® |
| 08.02.04 | Formulary | |
Ropeginterferon Alfa-2b Besremi® |
| 10.01.03 | Formulary | |
Sarilumab Kevzara® |
| 13.05.03 | Formulary | |
Secukinumab Cosentyx® |
| 05.03.03.02 | Formulary | |
Sofosbuvir and Velpatasvir Epclusa® |
| 06.05.01 | Formulary | |
Somatropin |
| 05.03.01 | Formulary | |
Tenofovir alafenamide, elvitegravir, cobicistat & emtricitabine Genvoya® |
| 06.06.01 | Formulary | |
Teriparatide |
| 13.05.03 | Formulary | |
Tildrakizumab Ilumetri® |
| 10.01.03 | Formulary | |
Tocilizumab Biosimilars avaliable |
| 06.05.02 | Formulary | |
Tolvaptan |
| 13.05.03 | Formulary | |
Ustekinumab Stelara® |